As of September 2023 it is on the FDA's Category 2 list of bulk drug substances that may not be compounded due to significant safety risks, and the agency has scheduled a Pharmacy Compounding Advisory Committee (PCAC) review for July 2026 covering proposed uses in opioid withdrawal, chronic insomnia, and narcolepsy
Users who have achieved significant results may choose to continue at a maintenance dose, take a break and reassess, or adjust their protocol in consultation with a healthcare provider
Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, et al
Alternative Names: Cu-GHK
It is essential to inform our practitioners about any known allergies or medical conditions before the treatment to ensure your safety and well-being
The options may be chosen on the product page BAC Water & Supplies EasyTouch Insulin Syringes 1mL 31G Price range: $9.99 through $19.99 Select options This product has multiple variants